Phencyclidine (PCP; angel dust) is a drug of abuse known to produce a behavioral state in humans resembling schizophrenia/psychosis. PCP is a noncompetitive NMDA receptor antagonist and produces a variety of behaviors in rats including circling. The behavioral effects of other noncompetitive NMDA receptor antagonists such as (+)-MK-801 are still being elucidated. Here, adult female rats were dosed with PCP (10 mg/kg, IP), or (+)-MK-801 (0.1 mg/kg, IP) and circling preference was recorded for 2 h before sacrifice to determine monoamine levels by HPLC/EC. Animals injected with PCP or (+)-MK-801 showed a preference to turn to the left (65% and 72%, respectively). PCP and (+)-MK-801 also produced a significant increase of 3,4-dihydroxyphenylace...
Phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, increases loc...
Antagonism of N-methyl-D-aspartate (NMDA) receptors by phencyclidine is thought to underlie its abil...
Dopamine is one of the major neurotransmitters in the mammalian brain and changes in its concentrati...
Phencyclidine (PCP) and phencyclidine-like drugs (TCP, dexoxadrol, MK-801, and SKF 10,047) were eval...
In the conditioned place preference test, phencyclidine (PCP) produces place aversion in naive rats,...
The recreational use of N-methyl-D-aspartate (NMDA) antagonist phencyclidine (PCP) and ketamine have...
Phencyclidine (PCP), a non-competitive NMDA/glutamate receptor antagonist, is a psychotomimetic drug...
Non-competitive NMDA receptor (NMDA-R) antagonists like ketamine, phencyclidine (PCP) and MK-801 are...
Phencyclidine (PCP) is an N-methyl-d-aspartate (NMDA) glutamate receptor channel noncompetitive anta...
Rationale N-methyl-D-aspartate receptor (NMDA-R) hypofunction has been proposed to account for the p...
Schizophrenia is a severe psychiatric disorder with about 1% prevalance. NMDA receptor antagonists s...
The effects of psychostimulants (methamphetamine and phencyclidine) on behavior and brain neurotensi...
Phencyclidine (PCP) is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. Several stu...
Dopamine is one of the major neurotransmitters in the mammalian brain and changes in its concentrati...
Phencyclidine (PCP) is a psychotomimetic drug that elicits schizo-phrenia-like symptoms in healthy p...
Phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, increases loc...
Antagonism of N-methyl-D-aspartate (NMDA) receptors by phencyclidine is thought to underlie its abil...
Dopamine is one of the major neurotransmitters in the mammalian brain and changes in its concentrati...
Phencyclidine (PCP) and phencyclidine-like drugs (TCP, dexoxadrol, MK-801, and SKF 10,047) were eval...
In the conditioned place preference test, phencyclidine (PCP) produces place aversion in naive rats,...
The recreational use of N-methyl-D-aspartate (NMDA) antagonist phencyclidine (PCP) and ketamine have...
Phencyclidine (PCP), a non-competitive NMDA/glutamate receptor antagonist, is a psychotomimetic drug...
Non-competitive NMDA receptor (NMDA-R) antagonists like ketamine, phencyclidine (PCP) and MK-801 are...
Phencyclidine (PCP) is an N-methyl-d-aspartate (NMDA) glutamate receptor channel noncompetitive anta...
Rationale N-methyl-D-aspartate receptor (NMDA-R) hypofunction has been proposed to account for the p...
Schizophrenia is a severe psychiatric disorder with about 1% prevalance. NMDA receptor antagonists s...
The effects of psychostimulants (methamphetamine and phencyclidine) on behavior and brain neurotensi...
Phencyclidine (PCP) is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. Several stu...
Dopamine is one of the major neurotransmitters in the mammalian brain and changes in its concentrati...
Phencyclidine (PCP) is a psychotomimetic drug that elicits schizo-phrenia-like symptoms in healthy p...
Phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, increases loc...
Antagonism of N-methyl-D-aspartate (NMDA) receptors by phencyclidine is thought to underlie its abil...
Dopamine is one of the major neurotransmitters in the mammalian brain and changes in its concentrati...